Financhill
Back

Diebold Nixdorf Quote, Financials, Valuation and Earnings

Diebold Nixdorf Price Quote

$38.87
-0.81 (-2.04%)
(Updated: November 14, 2024 at 12:35 PM ET)

Diebold Nixdorf Key Stats

Sell
18
Diebold Nixdorf (DBD) is a Sell

Day range:
$39.45 - $41.77
52-week range:
$21.45 - $51.81
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.43%

Volume:
228.7K
Avg. volume:
203.4K
1-year change:
82.52%
Market cap:
$1.5B
Revenue:
$0
EPS:
$0.13

How Much Does Diebold Nixdorf Make?

Data Unavailable

Is Diebold Nixdorf Growing As A Company?

  • What Is Diebold Nixdorf's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.01%
  • What Is Diebold Nixdorf's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Diebold Nixdorf Stock Price Performance

  • Did Diebold Nixdorf Stock Go Up Last Month?
    Diebold Nixdorf share price went down by -13.59% last month
  • Did DBD's Share Price Rise Over The Last Year?
    DBD share price rose by 82.52% over the past 1 year

What Is Diebold Nixdorf 52-Week High & Low?

Diebold Nixdorf Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Diebold Nixdorf?

  • How Much Debt Does Diebold Nixdorf Have?
    Total long term debt quarterly is $1.1B
  • How Much Cash Does Diebold Nixdorf Have?
    Cash and short term investments quarterly total is $262.4M
  • What Is Diebold Nixdorf’s Book Value Per Share?
    Book value per share is 28.37

Is Diebold Nixdorf Cash Flow Positive?

Data Unavailable

Diebold Nixdorf Return On Invested Capital

Data Unavailable

Diebold Nixdorf Earnings Date & Stock Price

Diebold Nixdorf Competitors

  • Who Are Diebold Nixdorf's Competitors?
    Below is a list of companies who compete with Diebold Nixdorf or are related in some way:
    • BM Technologies Inc (BMTX)
    • Castellum Inc (CTM)
    • Cognizant Technology Solutions Corp (CTSH)
    • ExlService Holdings Inc (EXLS)
    • Marti Technologies Inc (MRT)

Diebold Nixdorf Dividend Yield

Diebold Nixdorf Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -38.6%
Revenue: 0.53% -0.26%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 57.50
Upside from Last Price: 44.91%

Major Shareholders

  • How many DBD shares are owned by institutional investors?
    63M DBD shares are owned by institutional investors
  • How many DBD shares are owned by insiders?
    5.5M DBD shares are owned by insiders